15 minutes delayed
Comments
Loading...
Humanigen Inc
HGENOTC
Humanigen Inc (OTC:HGEN) Stock, Analyst Ratings, Price Targets, Forecasts
Humanigen Inc has a consensus price target of $2.91 based on the ratings of 6 analysts. The high is $9 issued by Jefferies on September 10, 2021. The low is $0.15 issued by Cantor Fitzgerald on January 11, 2023. The 3 most-recent analyst ratings were released by Credit Suisse, Cantor Fitzgerald, and Roth Capital on April 3, 2023, January 11, 2023, and July 13, 2022, respectively. With an average price target of $0.88 between Credit Suisse, Cantor Fitzgerald, and Roth Capital, there's an implied 441566.67% upside for Humanigen Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Credit Suisse
Cantor Fitzgerald
Roth Capital
Jefferies
1calculated from analyst ratings
Analyst Ratings for Humanigen Inc
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/03/2023 | Buy Now | 249900% | Credit Suisse | Tiago Fauth | → $0.5 | Reiterates | → Underperform | Get Alert |
| 01/11/2023 | Buy Now | 74900% | Cantor Fitzgerald | Louise Chen | → $0.15 | Reinstates | → Neutral | Get Alert |
| 07/13/2022 | Buy Now | 999900% | Roth Capital | Tony Butler | $13 → $2 | Downgrade | Buy → Neutral | Get Alert |
| 07/13/2022 | Buy Now | 999900% | Cantor Fitzgerald | Louise Chen | $30 → $2 | Downgrade | Overweight → Neutral | Get Alert |
| 07/13/2022 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis | — | Downgrade | Buy → Neutral | Get Alert |
| 09/10/2021 | Buy Now | 4499900% | Jefferies | Kelly Shi | — | Downgrade | Buy → Hold | Get Alert |
| 09/09/2021 | Buy Now | — | JP Morgan | Eric Joseph | — | Downgrade | Neutral → Underweight | Get Alert |
| 09/09/2021 | Buy Now | 13999900% | HC Wainwright & Co. | Joseph Pantginis | $36 → $28 | Maintains | Buy | Get Alert |
| 08/13/2021 | Buy Now | 11999900% | Credit Suisse | Tiago Fauth | — | Maintains | Outperform | Get Alert |
| 08/10/2021 | Buy Now | 15999900% | Roth Capital | Tony Butler | — | Maintains | Buy | Get Alert |
FAQ
What is the target price for Humanigen Inc (HGEN) stock?
The latest price target for Humanigen Inc (OTC:HGEN) was reported by Credit Suisse on April 3, 2023. The analyst firm set a price target for $0.50 expecting HGEN to rise to within 12 months (a possible 249900.00% upside). 0 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Humanigen Inc (HGEN)?
The latest analyst rating for Humanigen Inc (OTC:HGEN) was provided by Credit Suisse, and Humanigen Inc reiterated their underperform rating.
When was the last upgrade for Humanigen Inc (HGEN)?
There is no last upgrade for Humanigen Inc
When was the last downgrade for Humanigen Inc (HGEN)?
The last downgrade for Humanigen Inc happened on July 13, 2022 when Roth Capital changed their price target from $13 to $2 for Humanigen Inc.
When is the next analyst rating going to be posted or updated for Humanigen Inc (HGEN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Humanigen Inc, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Humanigen Inc was filed on April 3, 2023 so you should expect the next rating to be made available sometime around April 3, 2024.
Is the Analyst Rating Humanigen Inc (HGEN) correct?
While ratings are subjective and will change, the latest Humanigen Inc (HGEN) rating was a reiterated with a price target of $0.00 to $0.50. The current price Humanigen Inc (HGEN) is trading at is $0.00, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.